Although cancer genomics is a powerful tool to understand cancer and develop diagnostic tools, the contribution of the microbiome in cancer diagnosis and clinical assessment is much less studied. Elinav, Greten and colleagues provide their respective views on how studying cancer metagenomes could facilitate identification, diagnosis and staging of different tumor types.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions
Microbiome Open Access 19 August 2022
-
Classification and prediction of Mycobacterium Avium subsp. Paratuberculosis (MAP) shedding severity in cattle based on young stock heifer faecal microbiota composition using random forest algorithms
Animal Microbiome Open Access 14 November 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Viaud, S. et al. Science 342, 971–976 (2013).
Sivan, A. et al. Science 350, 1084–1089 (2015).
Gopalakrishnan, V. et al. Science 359, 97–103 (2018).
Poore, G. D. et al. Nature 579, 567–574 (2020).
Bullman, S. et al. Science 358, 1443–1448 (2017).
Eisenhofer, R. et al. Trends Microbiol. 27, 105–117 (2019).
Geller, L. T. et al. Science 357, 1156–1160 (2017).
Zeevi, D. et al. Cell 163, 1079–1094 (2015).
Nemet, I. et al. Cell 180, 862–877.e22 (2020).
Riquelme, E. et al. Cell 178, 795–806.12 (2019).
Ma, C. et al. Science 360, eaan5931 (2018).
Human Microbiome Project Consortium. Nature 486, 207–214 (2012).
Roy, S. & Trinchieri, G. Nat. Rev. Cancer 17, 271–285 (2017).
Pagès, F. et al. Lancet 391, 2128–2139 (2018).
Acknowledgements
L.A. received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie Grant Agreement No. 842203. E.E. is the incumbent of the Sir Marc and Lady Tania Feldmann Professorial Chair, a senior fellow at the Canadian Institute of Advanced Research (CIFAR) and an international scholar at the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. T.F.G. is supported by the Intramural Research Program of the NIH, NCI (ZIA BC 011344).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
E.E. is a scientific consultant for DayTwo and BiomX.
Rights and permissions
About this article
Cite this article
Adlung, L., Elinav, E., Greten, T.F. et al. Microbiome genomics for cancer prediction. Nat Cancer 1, 379–381 (2020). https://doi.org/10.1038/s43018-020-0059-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-020-0059-x
This article is cited by
-
A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions
Microbiome (2022)
-
A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma
British Journal of Cancer (2022)
-
Classification and prediction of Mycobacterium Avium subsp. Paratuberculosis (MAP) shedding severity in cattle based on young stock heifer faecal microbiota composition using random forest algorithms
Animal Microbiome (2021)
